title: [Endocrine therapy for postmenopausal breast cancer (role of cycline D1)].
authors.forename: A G
authors.initials: AG
authors.lastname: Manikhas
authors.forename: V A
authors.initials: VA
authors.lastname: Skvortsov
authors.forename: G M
authors.initials: GM
authors.lastname: Manikhas
authors.forename: G A
authors.initials: GA
authors.lastname: Raskin
authors.forename: A S
authors.initials: AS
authors.lastname: Oganesian
authors.forename: A K
authors.initials: AK
authors.lastname: Shemerovskiĭ
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D019938:Cyclin D1 / Q000378:metabolism*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017698:Postmenopause; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen; D019938:Cyclin D1